Expanding Selection of Tubulin & TOPI Inhibitor Payloads for Improved Tumor Specific Delivery by Peptide Drug Conjugate

Time: 1:15 pm
day: Conference Day Two


  • Considering the stability of linker-warhead peptide conjugates when working with TOPI inhibitor and tubulin inhibitors
  • Improving tumor specificity of warhead delivery for improved therapeutic window
  • Describing preclinical efficacy and safety profile, both clinical and non-clinical for Auristatin and Topo1 assets